Tuberculosis tests like sputum, blood and CBNAAT help in early detection. Here's a simple guide to TB symptoms, diagnosis and ...

RBC projects a 7% compound annual growth rate in sales between 2024 and 2027, with adjusted EBITDA margins rising from 33.2% in 2024 to 36.3% in 2027. This translates into a 10% CAGR for adjusted ...

In recently reported case studies, nemolizumab, approved for two indications associated with itch, has been reported to be effective in alleviating itch in a variety of other conditions.

Qiagen N.V. (NYSE: QGEN) Q2 2025 Earnings Conference Call August 6, 2025 9:30 AM ET Company Participants John Gilardi - Vice President of Corporate Communications & Investor Relations Roland ...

QuantiFERON grew 11% CER supported by solid gains in the Americas but also in EMEA as we maintain momentum in driving conversion of latent TB testing for the traditional skin test.

The firm saw an increase in diagnostics solutions sales in the second quarter, particularly within its QuantiFeron and QiaStat-Dx businesses.

QIAstat-Dx and QuantiFERON posted strong double-digit growth, while QIAcuity and QIAGEN Digital Insights continued to expand their contributions. Sample technologies saw good demand for automated ...

New Student InformationA: Invoices will be issued in whenever charges are posted to your account. For new students, we advise waiting until after arrival to campus to complete payment since charges ...